With a proficient background in technical sales and data analysis, Kyle has contributed to the strategic expansion of disruptive technologies in both the pharmaceutical and biotech sectors. Prior to joining Bioionix, his tenure at Caris Life Sciences and Adaptive Biotechnologies Corp. involved advancing community physician advocacy and making cutting-edge medical diagnostics accessible, reflecting his commitment to innovation and industry transformation.